Glassware for Scientific Experiments
Reading Time: < 1 minute
Financial
-PBoC to conduct cny 1tn 1-year MLF on Nov 25 which makes its net injection cny 100bn in Nov.
 
Sector News
-Shanghai Government issued measures for comprehensively deepening the reform of drug and medical device regulation and promoting the high-quality development of the pharmaceutical Industry, which mentioned plans to promote the expansion of medical service items and the scope of medical insurance payments for medical consumables, and support eligible innovative drugs in having their clinical trial review and approval timelines shortened to 30 working days.
 
Co Focus
 
-CATL signed strategic cooperation contract with Yibin city and aiming to build up zero-carbon eco-cluster in 5 years.
 
-CATL and Wuliangye reached strategic cooperation in promoting deep integration of tradition baijiu and new energy tech.
 
-Tonze New Energy (002759 CH) said on the interactive platform that co’s lithium hexafluorophosphate production is currently operating at full capacity with all output being sold, and this trend is expected to continue through the 1Q of next year.
 
Nov 24 Block Trade Info
 
*Discount
 
-Eazytec (688258 CH) saw 29 block trades worth 91.95mn at 58.94yuan per share, 15.87pct discount from last closing.
 
-Jianghua Micro-electronic (603078 CH) saw 22 block trades worth 75.33mn at 15.83yuan per share, 11.17pct discount from last closing.
 
-Zhongtian Rocket (003009 CH) saw 15 block trades worth 57.90mn at 46.08yuan per share, 16.37pct discount from last closing.
 

For more insights, please visit Orient Futures Singapore’s research platform, Finoview.

Disclaimer

We, Orient Futures International (Singapore) Pte. Ltd. (“OFIS”) (UEN No. 201831776Z), hold a capital markets services licence (CMS100869) from the Monetary Authority of Singapore for dealing in capital market products such as futures/derivatives contracts, and spot foreign exchange contracts for the purposes of leveraged foreign exchange trading, and is an Exempt Financial Adviser. For more information about OFIS, please check the MAS Financial Institutions Directory by clicking here.

All content, materials, information, data, statistics, features, research, documents or reports available on our website (including this article) which are financial in nature (the “Content”) are governed by our Terms of Use. By accessing, using or downloading any Content, you are deemed to have consented and agreed to the Terms of Use.

We distribute information/research (which may be prepared by us directly or produced by our foreign affiliated companies within the Orient Group of companies) pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. The information/research herein is prepared and distributed in Singapore and is intended for our clients who are Accredited Investors, Expert Investors or Institutional Investors only. If you are not an Accredited Investor, Expert Investor or Institutional Investor, you hereby acknowledge and agree that you are not the intended audience of all Content available on our website, and you undertake to immediately cease your access to any Content available on our website.

You agree to access and accept all Content available on our website on an “as-is” and “as available” basis. You agree that OFIS shall not have any responsibility or liability arising out of or in connection with, and you agree to waive the right to bring any claims or raise any complaints against OFIS in respect of any Content available on our website. OFIS shall also not be liable for any damage, loss or liability of any kind (whether actual, anticipated, consequential, special, economic or otherwise) caused as a result (direct or indirect) of the use of, or inability to access or use, the website, including but not limited to any damage, loss or liability suffered as a result of your reliance on the Content or our website.

OFIS does not make any representations, and hereby disclaim all warranties, express or implied, statutory or otherwise to the extent permitted by law, in respect of our website and all Content therein. To the fullest extent permissible, OFIS does not warrant and hereby disclaims any warranty as to the accuracy, correctness, completeness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the Content.

All Content available on our website are general in nature and have been prepared without any consideration of your investment objectives, financial situations or needs. You should consider the appropriateness of any Content available on our website having regard to your personal circumstances before making any investment decisions. You should take into account your investment objectives and financial situation and seek advice from an independent financial advisor under a separate engagement if necessary.

Subscribe to our weekly newsletter to get the latest market news